Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29341834

Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Mar 10
First author
Siegel DS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Siegel DS
      type
      Author
    2. name
      Dimopoulos MA
      type
      Author
    3. name
      Ludwig H
      type
      Author
    4. name
      Facon T
      type
      Author
    5. name
      Goldschmidt H
      type
      Author
    6. name
      Jakubowiak A
      type
      Author
    7. name
      San-Miguel J
      type
      Author
    8. name
      Obreja M
      type
      Author
    9. name
      Blaedel J
      type
      Author
    10. name
      Stewart AK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Siegel DS
      type
      Author
    2. name
      Dimopoulos MA
      type
      Author
    3. name
      Ludwig H
      type
      Author
    4. name
      Facon T
      type
      Author
    5. name
      Goldschmidt H
      type
      Author
    6. name
      Jakubowiak A
      type
      Author
    7. name
      San-Miguel J
      type
      Author
    8. name
      Obreja M
      type
      Author
    9. name
      Blaedel J
      type
      Author
    10. name
      Stewart AK
      type
      Author
    bibliography ids
    1. nci-bib-c80cc654e0bfddc611568876
    book metadata
    content sha256
    f40782e7b81ceff1c1ef6feccdb47bf859ae10913abac90358a08a195ec7a897
    document type
    citation
    dois
    1. 10.1200/JCO.2017.76.5032
    electronic publication date
    display
    2018 Jan 17
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29341834
    immutable id
    pubmed:29341834@f40782e7b81ceff1c1ef6feccdb47bf859ae10913abac90358a08a195ec7a897
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    8
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    728-734
    volume
    36
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29341834
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      cdf7075e464a99fba1b281ddaa666d0a5329fbca84f9936d98a1d758a03a1b8d
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 Mar 10
      precision
      day
      year
      2018
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29341834/
      title
      Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.

      Preserved source evidence · Not medical advice